TLSI TriSalus Life Sciences Inc

Price (delayed)

$5.73

Market cap

$155.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.67

Enterprise value

$153.23M

Highlights
TLSI's EPS has soared by 97% YoY and by 60% QoQ
The gross profit has soared by 82% YoY and by 20% QoQ
TriSalus Life Sciences's equity has soared by 81% YoY but it has decreased by 35% from the previous quarter
TriSalus Life Sciences's quick ratio has soared by 50% YoY but it has decreased by 45% from the previous quarter
TriSalus Life Sciences's net income has decreased by 34% YoY and by 8% QoQ

Key stats

What are the main financial stats of TLSI
Market
Shares outstanding
27.16M
Market cap
$155.62M
Enterprise value
$153.23M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
6.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.97
Earnings
Revenue
$21.98M
EBIT
-$63.96M
EBITDA
-$63.18M
Free cash flow
-$51.52M
Per share
EPS
-$2.67
Free cash flow per share
-$2.21
Book value per share
-$1.33
Revenue per share
$0.94
TBVPS
$0.72
Balance sheet
Total assets
$17.89M
Total liabilities
$52.81M
Debt
$1.58M
Equity
-$34.92M
Working capital
-$1.2M
Liquidity
Debt to equity
-0.05
Current ratio
0.92
Quick ratio
0.57
Net debt/EBITDA
0.04
Margins
EBITDA margin
-287.4%
Gross margin
86.7%
Net margin
-291.1%
Operating margin
-255.1%
Efficiency
Return on assets
-272.4%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-1,830%
Return on sales
-290.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TLSI stock price

How has the TriSalus Life Sciences stock price performed over time
Intraday
3.24%
1 week
9.98%
1 month
0.7%
1 year
-45.94%
YTD
-32.19%
QTD
3.8%

Financial performance

How have TriSalus Life Sciences's revenue and profit performed over time
Revenue
$21.98M
Gross profit
$19.07M
Operating income
-$56.08M
Net income
-$63.99M
Gross margin
86.7%
Net margin
-291.1%
The gross profit has soared by 82% YoY and by 20% QoQ
The revenue has surged by 69% year-on-year and by 19% since the previous quarter
TriSalus Life Sciences's operating income has decreased by 43% YoY and by 2.8% from the previous quarter
TriSalus Life Sciences's net income has decreased by 34% YoY and by 8% QoQ

Growth

What is TriSalus Life Sciences's growth rate over time

Valuation

What is TriSalus Life Sciences stock price valuation
P/E
N/A
P/B
N/A
P/S
6.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.97
TLSI's EPS has soared by 97% YoY and by 60% QoQ
TriSalus Life Sciences's equity has soared by 81% YoY but it has decreased by 35% from the previous quarter
The revenue has surged by 69% year-on-year and by 19% since the previous quarter
TLSI's P/S is 23% below its last 4 quarters average of 7.9

Efficiency

How efficient is TriSalus Life Sciences business performance
TLSI's ROS is up by 20% YoY and by 9% QoQ
TriSalus Life Sciences's ROA has decreased by 11% from the previous quarter

Dividends

What is TLSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLSI.

Financial health

How did TriSalus Life Sciences financials performed over time
The company's total assets is 66% lower than its total liabilities
TLSI's total liabilities has soared by 120% YoY and by 2.2% QoQ
TriSalus Life Sciences's quick ratio has soared by 50% YoY but it has decreased by 45% from the previous quarter
TLSI's debt is 105% greater than its equity
TriSalus Life Sciences's equity has soared by 81% YoY but it has decreased by 35% from the previous quarter
TriSalus Life Sciences's debt to equity has increased by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.